← Eichor
Study identifier: NCT07214493 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study on a Prosthetic Foot With Adjustable Heel Height

Condition: Lower Limb Amputation Above Knee · Lower Limb Amputation Below Knee  ·  Sponsor: Otto Bock France SNC

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Most prosthetic feet have a fixed heel height, which requires users to always wear shoes with the same heel height. A fixed heel height is a significant constraint, whereas the ability to choose one's clothing freely is an important aspect of coping with a physical disability. The Taleo Adjust is a prosthetic foot with a hydraulic ankle that allows the user to adjust the heel height from 0 to 7 cm, depending on the type of shoe worn. This study aims to evaluate the impact of an adjustable-heel-height foot on physical appearance and participation.

This description comes directly from the study's public registry record.

Talk to the study team

Aurelie LACROIX  ·  0033 (0)7 86 29 52 03  ·  aurelie.lacroix@ottobock.com

Always discuss trial participation with your own doctor first.

Locations (5)

CH CornouailleConcarneau, FranceRecruiting
CHU GrenobleÉchirolles, FranceRecruiting
IRR Louis PierquinNancy, FranceRecruiting
CRRF La TourmalineSaint-Herblain, FranceRecruiting
Institut Merle d'AubignéValenton, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07214493